Pancreatic Cancer

The number of cancer survivors with self-reported functional limitations throughout the United States has more than doubled over the past 2 decades, according to data published in JAMA Oncology.

Certain clinical and socioeconomic factors appeared to predict delays in time to treatment initiation among patients with various cancer types, according to study results published in JCO Oncology Practice.

Stool from long-term survivors of pancreatic adenocarcinoma had an increased relative abundance of the bacterial species Faecalibacterium prausnitzii and Akkermansia mucinophilia, according to data published in Cancer.

Perichemotherapy antibiotics appeared associated with longer survival among patients with metastatic pancreatic ductal adenocarcinoma treated with gemcitabine, according to retrospective study results.

Cancer Moonshot’s goal of reducing the cancer death rate by at least 50% over the next 25 years will depend upon greater access to and utilization of cancer prevention interventions, according to a study presented at an NCI press briefing.

The FDA announced several regulatory actions the past few weeks.

Receipt of perichemotherapy antibiotics correlated with improved survival in patients with metastatic pancreatic ductal adenocarcinoma treated with gemcitabine, but not fluorouracil, according to results in JAMA Network Open.

Elizabeth M. Jaffee, MD, will receive this year’s AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research.

Machine learning algorithms can help predict positive resection margin and lymph node metastases among patients with pancreatic ductal adenocarcinoma, according to study results.

A machine learning model may aid the detection and classification of tertiary lymphoid structures associated with gastrointestinal cancers based on routine tissue slides, according to research in JAMA Network Open.